TrialHaematologica2014

Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial.

Patrice Chevallier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.